However, CHRAC1 is known to potentially interact with YAP in breast cancer and exerts its tumorigenesis effect by enhancing YAP target oncogenes, which are involved in the Hippo pathway (Li S. et al., 2024). The gene discussed is CHRAC1; the disease is breast cancer.